Topamax
NDC 50458-647, topiramate, capsule, coated pellets, from Janssen Pharmaceuticals, Inc..
- Product NDC
- 50458-647
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020844
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-647 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE15 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50458-647-65 | 50458064765 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (50458-647-65) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/21628112-0c47-11df-95b3-498d55d89593
Use it
Look up 50458-647 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-647 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-647. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.